53 Results

People

  1. Gupta
    Gupta
  2. Chen
    Chen
  3. Aghajanian
    Aghajanian
  4. Makker
    Makker
  5. Motzer
    Motzer
  6. O'Cearbhaill
    O'Cearbhaill
  7. Weinsaft
    Weinsaft
  8. Abou-Alfa
    Abou-Alfa
  9. Bajorin
    Bajorin
  10. Diaz
    Diaz

Groups

  1. Department of Medicine (44)
  2. Solid Tumor Oncology Division (25)
  3. Division of Subspecialty Medicine (18)
  4. Cardiology (15)
  5. Hematologic Malignancies, Division of (8)
  6. Genitourinary Oncology Service (7)
  7. Survivorship Research (7)
  8. Thoracic Oncology (7)
  9. Gastrointestinal Oncology Service (5)
  10. Graduate Medical Education (5)
  1. "myocarditis"
Formats
  1. Journal Article (48)
  2. Guidelines (3)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Department of Medicine (44)
  2. Solid Tumor Oncology Division (25)
  3. Division of Subspecialty Medicine (18)
  4. Cardiology (15)
  5. Hematologic Malignancies, Division of (8)
  6. Genitourinary Oncology Service (7)

More Groups

People
  1. Dipti Gupta (10)
  2. Carol Chen (8)
  3. Richard Steingart (4)
  4. Carol Aghajanian (3)
  5. Jennifer Liu (3)
  6. Jonathan Weinsaft (3)

More People

Years
  1. 2025 (1)
  2. 2024 (9)
  3. 2023 (5)
  4. 2022 (8)
  5. 2021 (6)
  6. 2020 (8)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (5)
  2. Lancet Oncology (4)
  3. European Heart Journal (3)
  4. Journal of the American College of Cardiology (3)
  5. Annals of Oncology (2)
  6. Clinical Infectious Diseases (2)

More Publications

Publishers
  1. Elsevier Science, Inc. (9)
  2. Oxford University Press (9)
  3. Elsevier Inc. (7)
  4. Biomed Central Ltd (6)
  5. American Society of Clinical Oncology (3)
  6. Nature Publishing Group (3)

More Publishers

Results (53)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Axitinib plus immune checkpoint inhibitor: Evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events
    Guidelines

    Grünwald, V.; Voss, M. H.; Rini, B. I.; Powles, T.; Albiges, L.; Giles, R. H.; Jonasch, E.
    British Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Major adverse cardiovascular events and the timing and dose of corticosteroids in immune checkpoint inhibitor-associated myocarditis
    Research Letter

    Zhang, L.; Zlotoff, D. A.; Awadalla, M.; Mahmood, S. S.; Nohria, A.; Hassan, M. Z. O.; Thuny, F.; Zubiri, L.; Chen, C. L.; Sullivan, R. J.; more...
    Circulation (2020)

    Fulltext@MSK | Save
  • Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis
    Journal Article

    Zhang, L.; Awadalla, M.; Mahmood, S. S.; Nohria, A.; Hassan, M. Z. O.; Thuny, F.; Zlotoff, D. A.; Murphy, S. P.; Stone, J. R.; Golden, D. L. A.; more...
    European Heart Journal (2020)

    Fulltext@MSK | Save
  • Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101
    Journal Article

    Uemura, M.; Tomita, Y.; Miyake, H.; Hatakeyama, S.; Kanayama, H. O.; Numakura, K.; Takagi, T.; Kato, T.; Eto, M.; Obara, W.; more...
    Cancer Science (2020)

    Fulltext@MSK | Save
  • Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: Integrated analysis of three phase 1-2 trials
    Journal Article

    Drilon, A.; Siena, S.; Dziadziuszko, R.; Barlesi, F.; Krebs, M. G.; Shaw, A. T.; de Braud, F.; Rolfo, C.; Ahn, M. J.; Wolf, J.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: Integrated analysis of three phase 1-2 trials
    Journal Article

    Doebele, R. C.; Drilon, A.; Paz-Ares, L.; Siena, S.; Shaw, A. T.; Farago, A. F.; Blakely, C. M.; Seto, T.; Cho, B. C.; Tosi, D.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Global longitudinal strain and cardiac events in patients with immune checkpoint inhibitor-related myocarditis
    Journal Article

    Awadalla, M.; Mahmood, S. S.; Groarke, J. D.; Hassan, M. Z. O.; Nohria, A.; Rokicki, A.; Murphy, S. P.; Mercaldo, N. D.; Zhang, L.; Zlotoff, D. A.; more...
    Journal of the American College of Cardiology (2020)

    Fulltext@MSK | Save
  • Complete response and immune-mediated adverse effects with checkpoint blockade: Treatment of mismatch repair-deficient colorectal neuroendocrine carcinoma
    Journal Article

    Whitman, J.; Kardosh, A.; Diaz, L. Jr; Fong, L.; Hope, T.; Onodera, C.; Joseph, N.; Le, D.; Fisher, G.; Bergsland, E.
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study
    Journal Article

    Leighl, N. B.; Hellmann, M. D.; Hui, R.; Carcereny, E.; Felip, E.; Ahn, M. J.; Eder, J. P.; Balmanoukian, A. S.; Aggarwal, C.; Horn, L.; more...
    The Lancet Respiratory Medicine (2019)

    Fulltext@MSK | Save
  • Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors
    Journal Article

    Awadalla, M.; Golden, D. L. A.; Mahmood, S. S.; Alvi, R. M.; Mercaldo, N. D.; Hassan, M. Z. O.; Banerji, D.; Rokicki, A.; Mulligan, C.; Murphy, S. P. T.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save